David Shaw’s Praxis Precision Medicines PRAX Stock Holding History
Bought
Maintained
Sold
Other funds holding PRAX
BBA
David Shaw's PRAX Position: Q3 2026 in Review
David Shaw increased its Praxis Precision Medicines (PRAX) stake by 55% in Q3 2026, buying an estimated $940K and bringing the position to 7,980 shares worth $2.32M. The position accounts for ﹤0.01% of the portfolio, ranked #3122.
David Shaw first reported a position in PRAX in Q2 2021 and has held it in 13 quarters since. The position peaked at $11M in Q4 2025. 339 funds tracked by Wall St. Rank hold PRAX as of Q3 2026.
- David Shaw held 7,980 shares of Praxis Precision Medicines worth $2.32M as of Q3 2026.
- David Shaw bought 2,840 Praxis Precision Medicines shares in Q3 2026, an estimated $940K.
- Praxis Precision Medicines made up ﹤0.01% of David Shaw's portfolio in Q3 2026, its #3122 holding.
- David Shaw first reported a position in Praxis Precision Medicines in Q2 2021 and has held it in 13 quarters since.
- David Shaw's Praxis Precision Medicines position peaked at $11M in Q4 2025.
- 339 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q3 2026.
Based on D.E. Shaw & Co's 13F filing for Q3 2026, filed 16 Nov 2026.